Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection

Tae Yeob Kim

Clin Mol Hepatol. 2012;18(1):29-31. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.29

View: 7079 Download: 34 Crossref: 4

Original Article

Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin

Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol

Clin Mol Hepatol. 2011;17(3):183-188. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.183

View: 6881 Download: 34 Crossref: 3

Editorial

Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response

Jeong Heo

Clin Mol Hepatol. 2011;17(3):180-182. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.180

View: 6110 Download: 32

3

Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C

Heon Ju Lee , Jong Ryul Eun , Jae Won Choi , Kyung Ok Kim , Hee Jung Moon

Clin Mol Hepatol. 2008;14(1):46-57. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.46

View: 4497 Download: 20 Crossref: 15

1 |

Viewed By 5341	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5292	MAFLD: How is it different from NAFLD?
Viewed By 5187	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3882	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3837	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search